BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 21769100)

  • 1. Organic cation transporter 2 controls brain norepinephrine and serotonin clearance and antidepressant response.
    Bacq A; Balasse L; Biala G; Guiard B; Gardier AM; Schinkel A; Louis F; Vialou V; Martres MP; Chevarin C; Hamon M; Giros B; Gautron S
    Mol Psychiatry; 2012 Sep; 17(9):926-39. PubMed ID: 21769100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of organic cation transporter 2 and 3 may be involved in the mechanism of the antidepressant-like action of berberine.
    Sun S; Wang K; Lei H; Li L; Tu M; Zeng S; Zhou H; Jiang H
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Mar; 49():1-6. PubMed ID: 24246570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levomilnacipran (F2695), a norepinephrine-preferring SNRI: profile in vitro and in models of depression and anxiety.
    Auclair AL; Martel JC; Assié MB; Bardin L; Heusler P; Cussac D; Marien M; Newman-Tancredi A; O'Connor JA; Depoortère R
    Neuropharmacology; 2013 Jul; 70():338-47. PubMed ID: 23499664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of antidepressant activity of 1-(7-methoxy-2-methyl-1,2,3,4-tetrahydro-isoquinolin-4-YL)-cyclohexanol, a β-substituted phenylethylamine in mice.
    Dhir A; Malik S; Kessar SV; Singh KN; Kulkarni SK
    Eur Neuropsychopharmacol; 2011 Sep; 21(9):705-14. PubMed ID: 21277753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain organic cation transporter 2 controls response and vulnerability to stress and GSK3β signaling.
    Couroussé T; Bacq A; Belzung C; Guiard B; Balasse L; Louis F; Le Guisquet AM; Gardier AM; Schinkel AH; Giros B; Gautron S
    Mol Psychiatry; 2015 Jul; 20(7):889-900. PubMed ID: 25092247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the mechanism of antidepressant-like action of berberine chloride.
    Kulkarni SK; Dhir A
    Eur J Pharmacol; 2008 Jul; 589(1-3):163-72. PubMed ID: 18585703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical mechanism studies of venlafaxine by metabonomic method in rat model of depression.
    Fenli S; Feng W; Ronghua Z; Huande L
    Eur Rev Med Pharmacol Sci; 2013 Jan; 17(1):41-8. PubMed ID: 23329522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Organic cation transporter capable of transporting serotonin is up-regulated in serotonin transporter-deficient mice.
    Schmitt A; Mössner R; Gossmann A; Fischer IG; Gorboulev V; Murphy DL; Koepsell H; Lesch KP
    J Neurosci Res; 2003 Mar; 71(5):701-9. PubMed ID: 12584728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice.
    Deltheil T; Guiard BP; Cerdan J; David DJ; Tanaka KF; Repérant C; Guilloux JP; Coudoré F; Hen R; Gardier AM
    Neuropharmacology; 2008 Nov; 55(6):1006-14. PubMed ID: 18761360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antidepressant-like effect of the ethanolic extract from Suanzaorenhehuan Formula in mice models of depression.
    Liu J; Qiao W; Yang Y; Ren L; Sun Y; Wang S
    J Ethnopharmacol; 2012 May; 141(1):257-64. PubMed ID: 22366432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of concurrent organic cation transporter blockade on norepinephrine clearance inhibiting- and antidepressant-like actions of desipramine and venlafaxine.
    Bowman MA; Mitchell NC; Owens WA; Horton RE; Koek W; Daws LC;
    Eur J Pharmacol; 2020 Sep; 883():173285. PubMed ID: 32697958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of organic cation transporter 2 inhibition in potential mechanisms of antidepressant action.
    Wang K; Sun S; Li L; Tu M; Jiang H
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Aug; 53():90-8. PubMed ID: 24657329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antidepressant-like effect of the extracted of Kai Xin San, a traditional Chinese herbal prescription, is explained by modulation of the central monoaminergic neurotransmitter system in mouse.
    Zhou XJ; Liu M; Yan JJ; Cao Y; Liu P
    J Ethnopharmacol; 2012 Jan; 139(2):422-8. PubMed ID: 22138350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical pharmacology of TP1, a novel potent triple reuptake inhibitor with antidepressant properties.
    Tian JW; Jiang WL; Zhong Y; Meng Q; Gai Y; Zhu HB; Hou J; Xing Y; Li YX
    Neuroscience; 2011 Nov; 196():124-30. PubMed ID: 21925241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered aminergic neurotransmission in the brain of organic cation transporter 3-deficient mice.
    Vialou V; Balasse L; Callebert J; Launay JM; Giros B; Gautron S
    J Neurochem; 2008 Aug; 106(3):1471-82. PubMed ID: 18513366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Specifics of a dual action: toward new and more effective antidepressants?].
    Martin P
    Encephale; 1999 Jun; 25 Spec No 2():5-20; discussion 23-5. PubMed ID: 10434155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the chronic treatment effects of venlafaxine and other antidepressants on serotonin and norepinephrine transporters.
    Gould GG; Altamirano AV; Javors MA; Frazer A
    Biol Psychiatry; 2006 Mar; 59(5):408-14. PubMed ID: 16140280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. General Overview of Organic Cation Transporters in Brain.
    Koepsell H
    Handb Exp Pharmacol; 2021; 266():1-39. PubMed ID: 33782773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2'-NH2-MPTP in Swiss Webster mice: evidence for long-term (6-month) depletions in cortical and hippocampal serotonin and norepinephrine, differential protection by selective uptake inhibitors or clorgyline and functional changes in central serotonin neurotransmission.
    Andrews AM; Murphy DL
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1432-9. PubMed ID: 8263805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of dopamine-beta-hydroxylase-deficient mice to determine the role of norepinephrine in the mechanism of action of antidepressant drugs.
    Cryan JF; Dalvi A; Jin SH; Hirsch BR; Lucki I; Thomas SA
    J Pharmacol Exp Ther; 2001 Aug; 298(2):651-7. PubMed ID: 11454927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.